Welch Group, LLC Pfizer Inc Transaction History

Welch Group, LLC

$2.29 Billion
Q3 2024

A detailed history of Welch Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Welch Group, LLC holds 1,592,222 shares of PFE stock, worth $39.7 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares

1,592,222

Previous 1,560,118 2.06%

Holding current value

$39.7 Million

Previous $43.7 Million 5.56%

% of portfolio

2.01%

Previous 2.1%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$27.7 - $31.39 $889,280 - $1.01 Million	32,104 Added 2.06%	1,592,222 $46.1 Million
Q2 2024 Jul 17, 2024	BUY	$25.26 - $29.6 $1.71 Million - $2 Million	67,511 Added 4.52%	1,560,118 $43.7 Million
Q1 2024 Apr 09, 2024	BUY	$25.89 - $29.73 $14.7 Million - $16.9 Million	568,302 Added 61.48%	1,492,607 $41.4 Million
Q4 2023 Jan 22, 2024	SELL	$26.13 - $33.94 $1.45 Million - $1.88 Million	-55,431 Reduced 5.66%	924,305 $26.6 Million
Q3 2023 Oct 18, 2023	BUY	$32.09 - $37.51 $979,290 - $1.14 Million	30,517 Added 3.21%	979,736 $32.5 Million
Q2 2023 Jul 18, 2023	BUY	$36.12 - $41.79 $1.83 Million - $2.12 Million	50,693 Added 5.64%	949,219 $34.8 Million
Q1 2023 Apr 13, 2023	BUY	$39.39 - $51.28 $1.85 Million - $2.41 Million	47,028 Added 5.52%	898,526 $36.7 Million
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $691,922 - $903,228	16,573 Added 1.98%	851,498 $43.6 Million
Q3 2022 Oct 13, 2022	BUY	$43.76 - $53.42 $1.09 Million - $1.33 Million	24,915 Added 3.08%	834,925 $36.5 Million
Q2 2022 Jul 21, 2022	BUY	$46.53 - $55.17 $1.2 Million - $1.42 Million	25,747 Added 3.28%	810,010 $42.5 Million
Q1 2022 Apr 29, 2022	BUY	$45.75 - $56.69 $1.16 Million - $1.43 Million	25,293 Added 3.33%	784,263 $40.6 Million
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $1.12 Million - $1.66 Million	27,094 Added 3.7%	758,970 $44.8 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $26.2 Million - $33.6 Million	666,477 Added 1019.09%	731,876 $31.5 Million
Q2 2021 Jul 21, 2021	BUY	$35.91 - $40.68 $8,223 - $9,315	229 Added 0.35%	65,399 $2.56 Million
Q1 2021 Apr 23, 2021	BUY	$33.49 - $37.77 $87,308 - $98,466	2,607 Added 4.17%	65,170 $2.36 Million
Q4 2020 Jan 25, 2021	BUY	$33.47 - $42.56 $126,215 - $160,493	3,771 Added 6.41%	62,563 $2.3 Million
Q3 2020 Oct 28, 2020	SELL	$31.75 - $37.25 $127 - $149	-4 Reduced 0.01%	58,792 $2.16 Million
Q2 2020 Jul 22, 2020	BUY	$30.12 - $36.54 $109,335 - $132,640	3,630 Added 6.58%	58,796 $1.92 Million
Q1 2020 Apr 28, 2020	SELL	$27.03 - $38.62 $5,622 - $8,032	-208 Reduced 0.38%	55,166 $1.8 Million
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $16,361 - $18,567	497 Added 0.91%	55,374 $2.17 Million
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $584 - $758	18 Added 0.03%	54,877 $1.97 Million
Q2 2019 Jul 11, 2019	SELL	$36.98 - $41.52 $157,054 - $176,335	-4,247 Reduced 7.19%	54,859 $2.38 Million
Q1 2019 Apr 15, 2019	BUY	$37.5 - $41.2 $112,425 - $123,517	2,998 Added 5.34%	59,106 $2.51 Million
Q4 2018 Jan 10, 2019	BUY	$38.47 - $43.86 $2,385 - $2,719	62 Added 0.11%	56,108 $2.45 Million
Q3 2018 Nov 01, 2018	BUY	$34.47 - $41.81 $20,440 - $24,793	593 Added 1.07%	56,046 $2.47 Million
Q2 2018 Jul 30, 2018	BUY	$32.98 - $35.16 $205,003 - $218,554	6,216 Added 12.62%	55,453 $2.01 Million
Q1 2018 Apr 23, 2018	SELL	$31.91 - $37.02 $17,167 - $19,916	-538 Reduced 1.08%	49,237 $1.75 Million
Q4 2017 Feb 01, 2018	BUY	$33.26 - $35.29 $1.4 Million - $1.49 Million	42,203 Added 557.36%	49,775 $1.8 Million
Q3 2017 Nov 07, 2017	SELL	$31.0 - $34.15 $599,881 - $660,836	-19,351 Reduced 71.88%	7,572 $270,000
Q2 2017 Aug 07, 2017	BUY	N/A	26,923	26,923 $904,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch Group, LLC with notifications on news.

Account